bpc 157 recommended dosage human BPC-157 Dosing (Common Protocols), πΉ Oral / Subcutaneous, β’ 500 mcg daily, β’ Duration: 6 weeks, πΉ Intramuscular / Peritendinous, β’ 1 mg daily, β’ Duration: 6 weeks, β οΈ Note:, Not approved by FDA or Wolverine Stack: Healing Faster with
Description
Non-insertional or mid-portion tendinopathy occurs 2 to 6 centimeters above the heel

Most people start on the lowest dose and move up every 4 weeks

FDAs activities: Urogynecologic surgical mesh

Szakal, D